Paris - Delayed Quote EUR

Diagnostic Medical Systems S.A. (ALDMS.PA)

1.2400
+0.0050
+(0.40%)
At close: June 13 at 5:35:24 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
46,069
46,069
42,153
35,271
36,270
Cost of Revenue
27,677
27,677
26,310
21,437
22,939
Gross Profit
18,392
18,392
15,843
13,834
13,331
Operating Expense
19,713
19,713
25,046
18,949
13,819
Operating Income
-1,321
-1,321
-9,203
-5,115
-488
Net Non Operating Interest Income Expense
-1,812
-1,812
-445
-193
-296
Pretax Income
-2,611
-2,611
-9,834
-6,639
-2,593
Tax Provision
205
205
2
20
0
Net Income Common Stockholders
-2,880
-2,880
-4,946
-6,820
-3,875
Diluted NI Available to Com Stockholders
-2,880
-2,880
-4,946
-6,820
-3,875
Basic EPS
-0.61
-0.14
-0.28
-0.42
-0.24
Diluted EPS
-0.61
-0.14
-0.28
-0.42
-0.24
Basic Average Shares
17,696.7570
20,447.6000
17,463.4150
16,120.5560
16,120.5560
Diluted Average Shares
20,257.4330
22,772.2230
20,257.4330
16,120.5560
16,120.5560
Total Operating Income as Reported
-346
-346
-2,264
-5,875
-2,322
Total Expenses
47,390
47,390
51,356
40,386
36,758
Net Income from Continuing & Discontinued Operation
-2,880
-2,880
-4,946
-6,820
-3,875
Normalized Income
-3,182.2500
-3,182.2500
-9,764
-1,350
-112
Interest Income
243
243
140
33
0
Interest Expense
740
740
456
220
296
Net Interest Income
-1,812
-1,812
-445
-193
-296
EBIT
-1,871
-1,871
-9,378
-6,419
-2,297
EBITDA
702
702
-5,056
-2,951
1,402
Reconciled Cost of Revenue
27,677
27,677
26,310
21,437
22,939
Reconciled Depreciation
-67
-67
4,322
3,468
3,699
Net Income from Continuing Operation Net Minority Interest
-2,880
-2,880
-9,764
-4,511
-1,925
Total Unusual Items Excluding Goodwill
403
403
0
-3,024
-1,813
Total Unusual Items
403
403
0
-2,131
-1,813
Normalized EBITDA
299
299
-5,056
-820
3,215
Tax Rate for Calcs
0.0003
0.0003
0.0003
0.0003
0
Tax Effect of Unusual Items
100.7500
100.7500
0
-756
0
12/31/2021 - 4/12/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade